Skip to main content

Advertisement

The nonsense allele oblivious reveals a sensor of di-acylglycerides acting in conjunction with TLR2 and TLR6

Article metrics

The mammalian Toll-like receptors (TLRs) activate cells of the innate immune system when stimulated by diverse ligands of microbial origin. In some instances, these ligands are directly engaged by the TLRs; however, this is not necessarily true in all cases. TLR2 recognizes multiple, structurally disparate microbial ligands, consistent with a requirement for co-receptors in ligand binding. Using N-ethyl-N-nitrosourea, we generated the recessive immunodeficiency phenotype oblivious, in which macrophages show diminished awareness of the S-enantiomer of the di-acylated bacterial lipopeptide MALP-2 and lipoteichoic acid, together with spontaneous ocular colonization by Gram-positive organisms and hypersusceptibility to Staphylococcus aureus infection. Oblivious macrophages readily detect the tri-acylated bacterial lipopeptide PAM3CSK4 as well as zymosan, revealing that some TLR2 ligands are activated via an Oblivious-independent pathway. The gene responsible for the oblivious phenotype has been positionally cloned. In its ability to carry the lipoteichoic acid and MALP-2 signal to the transmembrane signaling receptors TLR2 and TLR6, Oblivious serves a function analogous to CD14, which concentrates the lipopolysacchardide signal for transduction by TLR4. Besides microbial molecules, oblivious also serves as a receptor for endogenous molecules and may mediate (some) of the inflammatory events involved in the development of atherosclerosis.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hoebe, K., Tabeta, K., Georgel, P. et al. The nonsense allele oblivious reveals a sensor of di-acylglycerides acting in conjunction with TLR2 and TLR6. Arthritis Res Ther 6, 13 (2004) doi:10.1186/ar1347

Download citation

Keywords

  • Staphylococcus Aureus
  • Innate Immune System
  • Inflammatory Event
  • Lipopeptide
  • TLR2 Ligand